Abdulla Sumaeya, Alemadi Budoor, Bin Shafar Latifa, Alsaeed Maryam
Department of Family Medicine, Dubai Health, Dubai, UAE.
Department of Endocrinology, Dubai Hospital, Dubai Health, Dubai, UAE.
BMC Public Health. 2025 Sep 25;25(1):3130. doi: 10.1186/s12889-025-24355-y.
Hypothyroidism is a common disorder worldwide with a varied prevalence. Limited data are available on the prevalence rates of hypothyroidism in the Middle East and North Africa (MENA) region, particularly the United Arab Emirates (UAE). This study aimed to evaluate the prevalence and associated factors of hypothyroidism among adult patients visiting primary healthcare centres (PHC) in Dubai, UAE.
A retrospective study was conducted using data from a registry maintained at the PHC of Dubai Health, from January 1, 2018, to December 31, 2020. The study included adults with thyroid function test (TFT) results and an International Classification of Diseases (ICD) 10 codes indicating hypothyroidism or subclinical hypothyroidism. Descriptive statistics were analysed for continuous and categorical variables, such as age, body mass index (BMI) and overweight or obese status. Chi-square and t-tests were employed to identify associations and differences between variables among individuals with and without hypothyroidism. The p-value ≤ 0.05 was considered statistically significant.
A total of 77,758 adult patients was analysed; among them, 49,995 (64.3%) were females and 27,762 (35.7%) were males; data was missing for 1 patient. The median age was 42 years, with a median BMI of 28.41. The overall prevalence of hypothyroidism was 2.1%, consisting of 91.4% overt hypothyroidism and 8.6% subclinical hypothyroidism. It was significantly higher in females (81.5%) than in males (18.5%). The highest prevalence (2.52%) was found in adults aged 35-44 years. Nearly half of the patients with hypothyroidism were obese (47%), followed by patients who were overweight (33.9%). Among patients with hypothyroidism, 0.73% had type 1 diabetes mellitus and no co-diagnoses of other autoimmune diseases; comorbidities included dyslipidemia (8%), hypertension (6.5%) and ischemic heart disease (1%).
The study revealed that hypothyroidism is common among patients visiting PHC in Dubai, with a prevalence rate similar to those reported in Europe and North America (0.3%-5.3%), but much lower than that in neighbouring Gulf countries, such as Bahrain (44%), Saudi Arabia (29%) and Jordan (26%). Moreover, the highest prevalence of hypothyroidism is found among young and middle-aged individuals, particularly women.
甲状腺功能减退是一种全球常见的疾病,患病率各不相同。关于中东和北非(MENA)地区,特别是阿拉伯联合酋长国(UAE)甲状腺功能减退的患病率数据有限。本研究旨在评估阿联酋迪拜初级医疗保健中心(PHC)成年患者中甲状腺功能减退的患病率及相关因素。
采用迪拜健康初级医疗保健中心2018年1月1日至2020年12月31日维护的登记数据进行回顾性研究。该研究纳入了有甲状腺功能测试(TFT)结果以及国际疾病分类(ICD)10编码表明甲状腺功能减退或亚临床甲状腺功能减退的成年人。对年龄、体重指数(BMI)和超重或肥胖状态等连续和分类变量进行描述性统计分析。采用卡方检验和t检验来确定甲状腺功能减退患者与非甲状腺功能减退患者之间变量的关联和差异。p值≤0.05被认为具有统计学意义。
共分析了77758名成年患者;其中,女性49995名(64.3%),男性27762名(35.7%);1名患者数据缺失。中位年龄为42岁,中位BMI为28.41。甲状腺功能减退的总体患病率为2.1%,其中显性甲状腺功能减退占91.4%,亚临床甲状腺功能减退占8.6%。女性患病率(81.5%)显著高于男性(18.5%)。35 - 44岁成年人的患病率最高(2.52%)。近一半的甲状腺功能减退患者肥胖(47%),其次是超重患者(33.9%)。在甲状腺功能减退患者中,0.73%患有1型糖尿病且无其他自身免疫性疾病的合并诊断;合并症包括血脂异常(8%)、高血压(6.5%)和缺血性心脏病(1%)。
该研究表明甲状腺功能减退在迪拜初级医疗保健中心就诊的患者中很常见,患病率与欧洲和北美报道的相似(0.3% - 5.3%),但远低于邻国海湾国家,如巴林(44%)、沙特阿拉伯(29%)和约旦(26%)。此外,甲状腺功能减退在中青年个体中患病率最高,尤其是女性。